Abstract: A touch panel, a manufacturing method thereof and a display device, which belong to the field of display technology, are disclosed. The touch panel includes a substrate (1), and a first light-transmitting insulation layer (2), a touch structure (3), and a second light-transmitting insulation layer (4), which are sequentially disposed on the substrate (1); the touch structure (3) includes a first touch layer (31), a third light-transmitting insulation layer (32), and a second touch layer (33), which are sequentially stacked; a refractive index of the first light-transmitting insulation layer (2) is greater than that of the third light-transmitting insulation layer (32); and a refractive index of the third light-transmitting insulation layer (32) is greater than that of the second light-transmitting insulation layer (4).

Abstract: A touch panel, a manufacturing method thereof and a display device, which belong to the field of display technology, are disclosed. The touch panel includes a substrate (1), and a first light-transmitting insulation layer (2), a touch structure (3), and a second light-transmitting insulation layer (4), which are sequentially disposed on the substrate (1); the touch structure (3) includes a first touch layer (31), a third light-transmitting insulation layer (32), and a second touch layer (33), which are sequentially stacked; a refractive index of the first light-transmitting insulation layer (2) is greater than that of the third light-transmitting insulation layer (32); and a refractive index of the third light-transmitting insulation layer (32) is greater than that of the second light-transmitting insulation layer (4).

Abstract: The invention generally relates to methods for analyzing stability of an active pharmaceutical agent. In certain aspects, the methods involve obtaining an active pharmaceutical agent, and distributing the active pharmaceutical agent into one or more microdroplets. The one or more microdroplets including the active pharmaceutical agent are then subjected to one or more conditions that force degradation of the active pharmaceutical agent in each of the one or more microdroplets. The one or more microdroplets are then analyzed to determine a ratio of the active pharmaceutical agent to that of a degradation product of the active pharmaceutical agent, thereby analyzing stability of an active pharmaceutical agent.

Abstract: A touch panel, a method for manufacturing the same and a display device are provided in the disclosure. The method for manufacturing the touch panel includes: forming a first conductive layer on a base substrate; performing a patterning process on the first conductive layer to form a first conductive layer pattern, wherein the first conductive layer pattern includes two etched regions and a non-etched region which are formed at a preset intersection position where a first touch electrode and a second touch electrode intersect with each other; forming an insulation pattern at the preset intersection position, wherein the insulation pattern is filled in the two etched regions and covers the non-etched region; forming a second conductive layer, wherein the first conductive layer and the second conductive layer constitute a conductive layer; and performing a patterning process on the conductive layer.

Abstract: A flexible touch screen, a manufacturing method thereof and a display device are provided. The manufacturing method includes: attaching a first protecting layer to a surface of a flexible substrate; attaching a surface of the flexible substrate away from the first protecting layer to a base substrate; removing the first protecting layer; forming a touch electrode layer on a side of the flexible substrate away from the base substrate; attaching a second protecting layer to the surface of the touch electrode layer; separating the flexible substrate from the base substrate; and removing the second protecting layer.

Abstract: A method for manufacturing a flexible touch panel, a flexible touch panel and a flexible touch device are provided. The method for manufacturing the flexible touch panel includes: forming a first indium tin oxide (ITO) film layer on a flexible base layer attached to a transparent substrate via an optical adhesive layer; and patterning the first ITO film layer to form a touch electrode of the flexible touch panel.

Abstract: A flexible touch screen, a manufacturing method thereof and a display device are provided. The manufacturing method includes: attaching a first protecting layer to a surface of a flexible substrate; attaching a surface of the flexible substrate away from the first protecting layer to a base substrate; removing the first protecting layer; forming a touch electrode layer on a side of the flexible substrate away from the base substrate; attaching a second protecting layer to the surface of the touch electrode layer; separating the flexible substrate from the base substrate; and removing the second protecting layer.

Abstract: A method for manufacturing a flexible touch panel, a flexible touch panel and a flexible touch device are provided. The method for manufacturing the flexible touch panel includes: forming a first indium tin oxide (ITO) film layer on a flexible base layer attached to a transparent substrate via an optical adhesive layer; and patterning the first ITO film layer to form a touch electrode of the flexible touch panel.

Abstract: The invention generally relates to methods for analyzing stability of an active pharmaceutical agent. In certain aspects, the methods involve obtaining an active pharmaceutical agent, and distributing the active pharmaceutical agent into one or more microdroplets. The one or more microdroplets including the active pharmaceutical agent are then subjected to one or more conditions that force degradation of the active pharmaceutical agent in each of the one or more microdroplets. The one or more microdroplets are then analyzed to determine a ratio of the active pharmaceutical agent to that of a degradation product of the active pharmaceutical agent, thereby analyzing stability of an active pharmaceutical agent.